Therapeutics News and Research

RSS

Cedars-Sinai launches new initiative to improve treatments for gastrointestinal, metabolic diseases

Cedars-Sinai has launched an initiative to accelerate the development of novel drugs, devices and therapies aimed at improving treatments for patients with gastrointestinal and metabolic diseases.

25 Jun 2018

Study links molecular changes in the brain to key behaviors in addiction

Changes in a brain signaling system contribute to the development of alcohol addiction-like behaviors in rats, according to a new study led by researchers at Linköping University, Sweden.

25 Jun 2018

Studying The Effects of Microgravity on Muscle Mass

Studying the effects of gravity on muscle cells can give us an insight into muscle wastage diseases, and potentially guide the development of new therapies. Professor Louis Yuge discusses his research and the cellular changes that occur in response to microgravity.

25 Jun 2018

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

A Delaware team including Erin Crowgey, PhD, associate director of Bioinformatics with Nemours Biomedical Research, has published a study in the peer-reviewed journal BMC Bioinformatics, showing that DNA patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients.

22 Jun 2018

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association meeting taking place this weekend in Orlando, Fla.

22 Jun 2018

Researchers discover drug compound that inhibits movement of cancer cells

Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body.

22 Jun 2018

UC San Diego launches new bacteriophage therapy center

With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging hard-won expertise to exploit a natural viral enemy of pathogenic bacteria, creating North America's first Center for Innovative Phage Applications and Therapeutics

22 Jun 2018

Researchers diagnose cerebral palsy using AI and next-generation sequencing

Researchers have shown that patients with spastic cerebral palsy (CP) can be identified using DNA methylation patterns in circulating blood cells.

22 Jun 2018

Lipid-scrambling DNA enzyme outperforms naturally occurring counterpart, say researchers

A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells.

22 Jun 2018

UC Riverside researcher receives grants to advance cancer, ALS research

Maurizio Pellecchia, who holds the Daniel Hays Chair in Cancer Research at the University of California, Riverside, has received two grants to continue his research aimed at finding therapeutics for cancer, amyotrophic lateral sclerosis, and other neurodegenerative diseases.

21 Jun 2018

Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment

Facing pediatric cancer as a patient or caregiver is challenging enough, but to understand the impact of the late effects of treatment is equally challenging to this population.

21 Jun 2018

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

21 Jun 2018

Follow-up study confirms success of physiological test for autism

One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum.

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Novus Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, announced receipt of final meeting minutes from the U.S. Food and Drug Administration following a Type C meeting held at the Company's request to discuss its OP-02 development program in otitis media.

19 Jun 2018

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its program to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.

19 Jun 2018

Scientists develop novel computational framework to support personalized cancer treatment

Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

19 Jun 2018

New study examines how the brain plays role in rheumatoid arthritis inflammation

In patients with chronic inflammatory conditions, such as rheumatoid arthritis, there has been limited understanding of how this inflammation affects the brain.

18 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Scientists discover how cancer-targeting 'Natural Killer' cells are fueled in the body

Scientists have just made an important discovery as to how cancer-targeting 'Natural Killer' cells are fueled in the body, which has significant implications for related therapies.

14 Jun 2018

Therapeutics News and Research

Cedars-Sinai launches new initiative to improve treatments for gastrointestinal, metabolic diseases

Study links molecular changes in the brain to key behaviors in addiction

Studying The Effects of Microgravity on Muscle Mass

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

Researchers discover drug compound that inhibits movement of cancer cells

UC San Diego launches new bacteriophage therapy center

Researchers diagnose cerebral palsy using AI and next-generation sequencing

Lipid-scrambling DNA enzyme outperforms naturally occurring counterpart, say researchers

UC Riverside researcher receives grants to advance cancer, ALS research

Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Follow-up study confirms success of physiological test for autism

Clinical trial targets metastatic colorectal cancer with new combination therapy

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Scientists develop novel computational framework to support personalized cancer treatment

New study examines how the brain plays role in rheumatoid arthritis inflammation

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Scientists discover how cancer-targeting 'Natural Killer' cells are fueled in the body

Advancing therapeutic biopolymer development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News